NanoViricides, Inc. (NASDAQOTCBB:NNVC)

CAPS Rating: 1 out of 5

Results 1 - 8 of 8

Recs

0
Member Avatar kevday (98.97) Submitted: 5/28/2013 9:27:27 AM : Underperform Start Price: $0.66 NNVC Score: -0.63

Far as I can tell, no real product or sales, just burning cash....

Recs

0
Member Avatar AnsgarJohn (49.47) Submitted: 5/28/2013 7:20:45 AM : Underperform Start Price: $0.66 NNVC Score: -0.63

Via penny stock website. Book value 8 cents per stock, no revenue, no profit.

Recs

0
Member Avatar PeterLeyssens (< 20) Submitted: 10/18/2011 4:07:03 PM : Outperform Start Price: $0.90 NNVC Score: -61.34

bet for a stock option

Recs

1
Member Avatar Allstar13913 (99.77) Submitted: 7/30/2011 9:24:35 PM : Underperform Start Price: $0.94 NNVC Score: +61.37

From TMFCandyMountain.

Just look at this website and tell me you don't think this stock is crap:

http://nanoviricides.com/index.html

Recs

0
Member Avatar BuffettJunior1 (97.57) Submitted: 5/4/2011 4:36:30 PM : Underperform Start Price: $1.35 NNVC Score: +73.76

Too easy!

Recs

1
Member Avatar kevin939516 (31.36) Submitted: 3/1/2011 6:45:09 PM : Outperform Start Price: $1.39 NNVC Score: -78.25

Sole developer of technology that can be used to teat and/or prevent any viral infection. Yes, they are still in production of this technology, but they've had alot of promisingresearch lately. Additional bonus: it is not a vaccine so it will not take years to be approved, and the FDA seems to be giving signs that they look forward to it.

Recs

0
Member Avatar Biotoday (35.42) Submitted: 10/7/2010 11:08:17 AM : Outperform Start Price: $1.06 NNVC Score: -79.72

From Accredited Investor grapevine. Great story with lots of promise.

Recs

1
Member Avatar LorenCobb (28.08) Submitted: 3/29/2010 2:35:17 PM : Outperform Start Price: $1.73 NNVC Score: -101.85

This tiny company is the sole developer of a unique and extremely promising nanotech approach to the creation of new vaccines. They have under development vaccines for all forms of influenza, HIV, hepatitis C, rabies, and dengue fever. I have followed them for the past three years, with growing conviction that they have what it takes.

Results 1 - 8 of 8

Featured Broker Partners


Advertisement